Pfizer, IBM and Microsoft launch Amicore

10 October 2001

Pfizer, IBM and Microsoft have launched Amicore, an independent softwareand services company aimed at reducing "the administrative workload and paperwork for physicians, allowing them to dedicate more time toward their mission of providing quality patient care." Amicore also announced the acquisition of PenChart Corp, a Connecticut, USA-based health care application developer, to form the core of the company's initial product offering and accelerate its product development strategy.

Pfizer, which joined forces with IBM and Microsoft earlier this year (Marketletter April 9), says that a recent customer study showed that PenChart software "almost entirely eliminated the cost of filing and retrieving paper medical records and reduced the cost of ordering prescription refills and of transcription services by over 80%."

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight